EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

A Mediterranean dietary pattern intervention does not improve cardiometabolic risk but does improve quality of life and body composition in an Aotearoa New Zealand population at increased cardiometabolic risk: A randomised controlled trial

Jeremy D Krebs iD, Amber Parry-Strong iD, Andrea Braakhuis, Anna Worthington, Troy L Merry, Richard B Gearry, Meika Foster, Mark Weatherall, Cheryl Davies, Jane Mullaney, Cecilia Ross, Denise Conroy und 2 weitere

Diabetes, Obesity and Metabolism · 2025-01 · 27 (1) · 368-376

DOI: 10.1111/dom.16030 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 29.10.2024. Verfasst von Jeremy D Krebs und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Otago, Wellington, Wellington, New Zealand. Hauptthemen laut MEDLINE: Diet, Mediterranean, Quality of Life, Metabolic Syndrome, Body Composition. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: High Value Nutrition National Science Challenge, Ministry of Business Innovation and Employment, New Zealand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To test if a New Zealand food–based Mediterranean diet (NZMedDiet) with behavioural intervention improves cardiometabolic health and wellbeing.

Methods

A randomised controlled trial comparing 12 weeks of the NZMedDiet to usual diet in participants with increased cardiometabolic risk (metabolic syndrome severity score [MetSSS] > 0.35). The intervention group was provided with food and recipes to meet 75% of their energy requirements, supported by a behavioural intervention to improve adherence. The primary outcome measure was (MetSSS) after 12 weeks.

Results

Two hundred individuals with mean (SD) age 49.9 (10.9) years of which 62% women were enrolled with their household/ whānau . After 12 weeks, the mean (SD) MetSSS was 1.0 (0.7) in the control ( n = 98) and 0.8 (0.5) in the intervention ( n = 102) group; estimated difference (95% confidence interval [CI]) of −0.05 (−0.16 to 0.06), p = 0.35. The Mediterranean diet score (PyrMDS) was greater in the intervention group 1.6 (1.1–2.1), p < 0.001, consistent with a change to a more Mediterranean dietary pattern. Weight reduced in the NZMedDiet group compared with control (−1.9 kg [−2.0 to −0.34]), p = 0.006 and wellbeing, assessed by the SF‐36 quality of life questionnaire, and improved across all domains. For example, the physical component summary score difference (95% CI) was 4.0 (2.4–5.7), p < 0.001, and the mental component summary score difference was 3.0 (0.7–5.2), p = 0.01.

Conclusion

In participants with increased cardiometabolic risk, food provision with a Mediterranean dietary pattern and a behavioural intervention did not improve metabolic risk scores but was associated with reduced weight and improved quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, MediterraneanQuality of LifeMetabolic SyndromeBody CompositionCardiometabolic Risk FactorsHumansFemaleMaleMiddle AgedNew ZealandAdultCardiovascular Diseases

Stichwörter der Autor:innen

cardiovascular diseaseclinical trialdietary interventionrandomised trial

Autor:innen und Institutionen

  • Department of Medicine, University of Otago, Wellington, Wellington, New Zealand.
  • Centre for Endocrine, Diabetes and Diabetes Research, Te Whatu Ora New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.
  • Discipline of Nutrition, School of Medical Sciences, University of Auckland, Auckland, New Zealand.
  • Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, New Zealand.
  • Department of Medicine, University of Otago, Christchurch, New Zealand.
  • Edible Research Ltd., Ohoka, New Zealand.

ORCID-Profile: Jeremy D Krebs, Amber Parry-Strong

Förderung

  • High Value Nutrition National Science Challenge, Ministry of Business Innovation and Employment, New Zealand

Zitieren

APA

Krebs, J. D., Parry-Strong, A., Braakhuis, A., Worthington, A., Merry, T. L., Gearry, R. B., Foster, M., Weatherall, M., Davies, C., Mullaney, J., Ross, C., Conroy, D., Rolleston, A., & Lithander, F. E. (2025). A Mediterranean dietary pattern intervention does not improve cardiometabolic risk but does improve quality of life and body composition in an Aotearoa New Zealand population at increased cardiometabolic risk: A randomised controlled trial. Diabetes, Obesity and Metabolism, 27(1), 368-376. https://doi.org/10.1111/dom.16030

Vancouver

Krebs JD, Parry-Strong A, Braakhuis A, Worthington A, Merry TL, Gearry RB, et al. A Mediterranean dietary pattern intervention does not improve cardiometabolic risk but does improve quality of life and body composition in an Aotearoa New Zealand population at increased cardiometabolic risk: A randomised controlled trial. Diabetes, Obesity and Metabolism. 2025;27(1):368-376. doi:10.1111/dom.16030

BibTeX
@article{Krebs2025,
  author = {Krebs, Jeremy D and Parry-Strong, Amber and Braakhuis, Andrea and Worthington, Anna and Merry, Troy L and Gearry, Richard B and Foster, Meika and Weatherall, Mark and Davies, Cheryl and Mullaney, Jane and Ross, Cecilia and Conroy, Denise and Rolleston, Anna and Lithander, Fiona E},
  title = {A Mediterranean dietary pattern intervention does not improve cardiometabolic risk but does improve quality of life and body composition in an Aotearoa New Zealand population at increased cardiometabolic risk: A randomised controlled trial},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  volume = {27},
  number = {1},
  pages = {368--376},
  doi = {10.1111/dom.16030}
}
Kostenlos starten →